Fox Chase Cancer Center

Fox Chase Cancer Center is a cancer treatment and research institution located in Philadelphia, Pennsylvania. Founded in 1904, it is one of the oldest and most respected cancer centers in the United States, and is recognized for its contributions to the understanding, diagnosis, and treatment of cancer.

History

The Fox Chase Cancer Center was established in 1904 as the American Oncologic Hospital. It was the first cancer hospital in the United States. In 1949, it merged with the Institute for Cancer Research to form the Fox Chase Cancer Center. The center has been a pioneer in cancer research and treatment, and has made significant contributions to the understanding of cancer and the development of new treatments.

Research

Fox Chase Cancer Center is renowned for its cancer research programs. The center's research focuses on understanding the basic biology of cancer, developing new treatments, and improving the quality of life for cancer patients. The center's research is organized into five programs: Cancer Biology, Cancer Prevention and Control, Molecular Therapeutics, Immune Cell Engineering, and Cancer Epigenetics.

Treatment

Fox Chase Cancer Center offers a wide range of cancer treatments, including surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapy. The center is known for its multidisciplinary approach to cancer care, which involves a team of specialists working together to develop a personalized treatment plan for each patient.

Education

In addition to its research and treatment programs, Fox Chase Cancer Center also offers educational programs for healthcare professionals, patients, and the public. These programs include residency and fellowship programs, continuing medical education courses, patient education resources, and community outreach programs.

Recognition

Fox Chase Cancer Center is consistently ranked among the top cancer hospitals in the United States by U.S. News & World Report. It is also designated as a Comprehensive Cancer Center by the National Cancer Institute, a recognition given to institutions that demonstrate excellence in cancer research, treatment, and education.